| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 8.02e-08 | 18 | 128 | 5 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.08e-07 | 19 | 128 | 5 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 2.41e-07 | 22 | 128 | 5 | GO:0016917 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.93e-06 | 130 | 128 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | GTP binding | TUBB TUBB2B OPA1 EFTUD2 TUBB6 TUBB3 TUBB4A TUBB4B GUCY2F RASL11A RASL11B GNAL | 9.63e-06 | 397 | 128 | 12 | GO:0005525 |
| GeneOntologyMolecularFunction | GTPase activity | TUBB TUBB2B OPA1 EFTUD2 TUBB6 TUBB3 TUBB4A TUBB4B RASL11A RASL11B GNAL | 1.26e-05 | 341 | 128 | 11 | GO:0003924 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.68e-05 | 50 | 128 | 5 | GO:0099095 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | TUBB TUBB2B OPA1 EFTUD2 TUBB6 TUBB3 TUBB4A TUBB4B GUCY2F RASL11A RASL11B GNAL | 2.61e-05 | 439 | 128 | 12 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | TUBB TUBB2B OPA1 EFTUD2 TUBB6 TUBB3 TUBB4A TUBB4B GUCY2F RASL11A RASL11B GNAL | 2.61e-05 | 439 | 128 | 12 | GO:0019001 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP8A2 TUBB MCM3 TUBB2B SMARCAD1 OPA1 EFTUD2 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B RASL11A RASL11B GNAL DNAH8 | 3.68e-05 | 775 | 128 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 6.07e-05 | 65 | 128 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 6.07e-05 | 65 | 128 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP8A2 TUBB MCM3 TUBB2B SMARCAD1 OPA1 EFTUD2 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B RASL11A RASL11B GNAL DNAH8 | 9.37e-05 | 839 | 128 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP8A2 TUBB MCM3 TUBB2B SMARCAD1 OPA1 EFTUD2 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B RASL11A RASL11B GNAL DNAH8 | 9.50e-05 | 840 | 128 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP8A2 TUBB MCM3 TUBB2B SMARCAD1 OPA1 EFTUD2 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B RASL11A RASL11B GNAL DNAH8 | 9.50e-05 | 840 | 128 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.37e-04 | 77 | 128 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.30e-04 | 86 | 128 | 5 | GO:0005254 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 4.03e-04 | 5 | 128 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 4.63e-04 | 100 | 128 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 4.72e-04 | 24 | 128 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 5.30e-04 | 103 | 128 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 8.28e-04 | 171 | 128 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 8.38e-04 | 7 | 128 | 2 | GO:0030628 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.27e-03 | 125 | 128 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | CCR1 chemokine receptor binding | 2.58e-03 | 12 | 128 | 2 | GO:0031726 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 2.58e-03 | 12 | 128 | 2 | GO:0017154 | |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRB1 GABRB2 GABRB3 GABRR1 ABI1 FMR1 FXR2 ACHE CAMK2B GJC1 GABRQ TUBB2B CLSTN2 NLGN1 MET FXR1 SV2B NR2E1 CNTNAP2 CTBP2 CACNA1G GNAL | 1.41e-07 | 976 | 128 | 22 | GO:0099536 |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse, modulating synaptic transmission | 2.33e-07 | 3 | 128 | 3 | GO:0099577 | |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse | 2.33e-07 | 3 | 128 | 3 | GO:0140244 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRB1 GABRB2 GABRB3 GABRR1 FMR1 FXR2 ACHE CAMK2B GJC1 GABRQ TUBB2B CLSTN2 NLGN1 MET FXR1 SV2B NR2E1 CNTNAP2 CTBP2 CACNA1G GNAL | 2.79e-07 | 931 | 128 | 21 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRB1 GABRB2 GABRB3 GABRR1 FMR1 FXR2 ACHE CAMK2B GJC1 GABRQ TUBB2B CLSTN2 NLGN1 MET FXR1 SV2B NR2E1 CNTNAP2 CTBP2 CACNA1G GNAL | 2.79e-07 | 931 | 128 | 21 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRB1 GABRB2 GABRB3 GABRR1 FMR1 FXR2 ACHE CAMK2B GJC1 GABRQ TUBB2B CLSTN2 NLGN1 MET FXR1 SV2B NR2E1 CNTNAP2 CTBP2 CACNA1G GNAL | 3.21e-07 | 939 | 128 | 21 | GO:0099537 |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 1.07e-06 | 30 | 128 | 5 | GO:1904862 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | FMR1 FN1 FXR2 ACHE CAMK2B CLSTN2 NLGN1 OPA1 MET FXR1 NR2E1 IL6ST PLXNB1 | 2.07e-06 | 418 | 128 | 13 | GO:0051962 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 2.38e-06 | 35 | 128 | 5 | GO:0007214 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | FMR1 FRMPD4 FN1 ATR CENPE DOCK11 ACHE CAMK2B ATP8A2 TUBB2B CLSTN2 NLGN1 OPA1 TGFB3 MET CCT6A VPS13D AVIL CNTNAP2 PAN2 HRG CDK5RAP2 HAS3 PLXNB1 | 3.16e-06 | 1366 | 128 | 24 | GO:0051130 |
| GeneOntologyBiologicalProcess | cellular response to histamine | 8.02e-06 | 7 | 128 | 3 | GO:0071420 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | FMR1 FN1 DOCK11 ACHE CAMK2B ATP8A2 TUBB2B NLGN1 OPA1 TGFB3 MET AVIL PLXNB1 | 1.26e-05 | 494 | 128 | 13 | GO:0031346 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.32e-05 | 354 | 128 | 11 | GO:0050769 | |
| GeneOntologyBiologicalProcess | regulation of translation at synapse, modulating synaptic transmission | 1.91e-05 | 9 | 128 | 3 | GO:0099547 | |
| GeneOntologyBiologicalProcess | cell junction organization | GABRB2 GABRB3 FMR1 FRMPD4 FN1 ACHE CAMK2B LRFN3 TUBB GJC1 CLSTN2 NLGN1 ITGB4 OPA1 TGFB3 CNTNAP2 HRG PLXNB1 | 3.26e-05 | 974 | 128 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 3.35e-05 | 198 | 128 | 8 | GO:0048813 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term neuronal synaptic plasticity | 3.71e-05 | 11 | 128 | 3 | GO:0048170 | |
| GeneOntologyBiologicalProcess | response to histamine | 4.93e-05 | 12 | 128 | 3 | GO:0034776 | |
| GeneOntologyBiologicalProcess | regulation of translation at synapse | 6.38e-05 | 13 | 128 | 3 | GO:0140243 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | GABRR1 FMR1 FXR2 ACHE CAMK2B TUBB2B CLSTN2 NLGN1 MET FXR1 SV2B NR2E1 CNTNAP2 GNAL | 6.52e-05 | 663 | 128 | 14 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | GABRR1 FMR1 FXR2 ACHE CAMK2B TUBB2B CLSTN2 NLGN1 MET FXR1 SV2B NR2E1 CNTNAP2 GNAL | 6.62e-05 | 664 | 128 | 14 | GO:0099177 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | FMR1 ATR DOCK11 CLSTN2 NLGN1 TGFB3 MET AVIL CNTNAP2 PAN2 HRG CDK5RAP2 HAS3 | 6.86e-05 | 582 | 128 | 13 | GO:0044089 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | FMR1 FN1 DOCK11 ACHE CAMK2B ATP8A2 TBC1D2 TUBB2B NLGN1 OPA1 TGFB3 MET AVIL NR2E1 HRG PLXNB1 | 7.09e-05 | 846 | 128 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of filopodium assembly | 7.15e-05 | 36 | 128 | 4 | GO:0051491 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | FMR1 FN1 DOCK11 ACHE CAMK2B ATP8A2 TBC1D2 TUBB2B NLGN1 OPA1 TGFB3 MET AVIL NR2E1 HRG PLXNB1 | 8.95e-05 | 863 | 128 | 16 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 1.09e-04 | 40 | 128 | 4 | GO:0048169 | |
| GeneOntologyBiologicalProcess | response to metformin | 1.14e-04 | 3 | 128 | 2 | GO:1901558 | |
| GeneOntologyBiologicalProcess | filopodium assembly | 1.25e-04 | 78 | 128 | 5 | GO:0046847 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | FMR1 FN1 FXR2 ACHE CAMK2B CLSTN2 NLGN1 OPA1 MET FXR1 NR2E1 IL6ST PLXNB1 | 1.40e-04 | 625 | 128 | 13 | GO:0051960 |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle | 1.45e-04 | 43 | 128 | 4 | GO:0042745 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.91e-04 | 134 | 128 | 6 | GO:0098661 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRB1 GABRB2 GABRB3 GABRR1 FMR1 CAMK2D GJC1 GABRQ NLGN1 MET CNTNAP2 CACNA1G | 1.91e-04 | 559 | 128 | 12 | GO:0042391 |
| GeneOntologyBiologicalProcess | cell junction assembly | GABRB2 GABRB3 FN1 ACHE LRFN3 GJC1 CLSTN2 NLGN1 ITGB4 CNTNAP2 HRG PLXNB1 | 2.25e-04 | 569 | 128 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ABI1 FN1 ACHE CAMK2B ATP8A2 TUBB2B NLGN1 OPA1 MET TUBB3 NTN4 NR2E1 CNTNAP2 PLXNB1 | 2.30e-04 | 748 | 128 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | dendrite development | 2.48e-04 | 335 | 128 | 9 | GO:0016358 | |
| GeneOntologyBiologicalProcess | neuron development | GABRB1 GABRB2 GABRB3 ABI1 FMR1 FN1 ACHE CAMK2B ATP8A2 ARFGEF1 TUBB2B NLGN1 OPA1 MET GDPD5 TUBB3 NTN4 AVIL NR2E1 CNTNAP2 PLXNB1 | 2.57e-04 | 1463 | 128 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | synapse organization | GABRB2 GABRB3 FMR1 FRMPD4 ACHE CAMK2B LRFN3 TUBB CLSTN2 NLGN1 OPA1 CNTNAP2 PLXNB1 | 3.40e-04 | 685 | 128 | 13 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 3.71e-04 | 515 | 128 | 11 | GO:0050767 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | FMR1 ATR DOCK11 LRFN3 TBC1D2 ARFGEF1 CLSTN2 NLGN1 TGFB3 MET TUBB4A SACS AVIL CNTNAP2 PAN2 HRG CDK5RAP2 HAS3 | 3.97e-04 | 1189 | 128 | 18 | GO:0044087 |
| GeneOntologyBiologicalProcess | regulation of filopodium assembly | 4.33e-04 | 57 | 128 | 4 | GO:0051489 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | FMR1 FN1 FXR2 ACHE CAMK2B OPA1 MET MALT1 FXR1 NR2E1 IL6ST PLXNB1 | 4.46e-04 | 614 | 128 | 12 | GO:0010720 |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 4.58e-04 | 103 | 128 | 5 | GO:0048814 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ABI1 FN1 ACHE CAMK2B ATP8A2 TUBB2B NLGN1 OPA1 MET TUBB3 NTN4 NR2E1 CNTNAP2 PLXNB1 | 4.63e-04 | 802 | 128 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | ATR CENPE CAMK2B CAMK2D PARP3 TUBB MCM3 TUBB2B TUBB6 MET TUBB3 TUBB4A TUBB4B MEIOC CDK5RAP2 ANAPC4 | 5.47e-04 | 1014 | 128 | 16 | GO:0000278 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ABI1 FN1 ACHE CAMK2B ATP8A2 TUBB2B NLGN1 OPA1 MET TUBB3 NTN4 NR2E1 CNTNAP2 PLXNB1 | 5.70e-04 | 819 | 128 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ATR CENPE CAMK2B PARP3 TBC1D2 ARFGEF1 NLGN1 OPA1 TGFB3 MET CCT6A TUBB4A VPS13D AVIL PAN2 HRG CDK5RAP2 PLXNB1 ANAPC4 | 6.17e-04 | 1342 | 128 | 19 | GO:0033043 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ABI1 FN1 ACHE CAMK2B ATP8A2 TUBB2B NLGN1 OPA1 MET TUBB3 NTN4 NR2E1 CNTNAP2 PLXNB1 | 6.20e-04 | 826 | 128 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 6.72e-04 | 112 | 128 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | synapse assembly | 6.86e-04 | 308 | 128 | 8 | GO:0007416 | |
| GeneOntologyBiologicalProcess | inhibitory chemical synaptic transmission | 7.86e-04 | 7 | 128 | 2 | GO:0098977 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 8.02e-04 | 67 | 128 | 4 | GO:0050775 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 8.96e-04 | 69 | 128 | 4 | GO:0010770 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 9.15e-04 | 180 | 128 | 6 | GO:0015698 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 9.15e-04 | 180 | 128 | 6 | GO:0060078 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 9.19e-04 | 248 | 128 | 7 | GO:0120032 | |
| GeneOntologyBiologicalProcess | dentate gyrus development | 9.24e-04 | 31 | 128 | 3 | GO:0021542 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 9.41e-04 | 249 | 128 | 7 | GO:0010976 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 9.45e-04 | 70 | 128 | 4 | GO:0060999 | |
| GeneOntologyBiologicalProcess | neuron projection development | ABI1 FMR1 FN1 ACHE CAMK2B ATP8A2 ARFGEF1 TUBB2B NLGN1 OPA1 MET GDPD5 TUBB3 NTN4 AVIL NR2E1 CNTNAP2 PLXNB1 | 9.81e-04 | 1285 | 128 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | 9.86e-04 | 251 | 128 | 7 | GO:0060491 | |
| GeneOntologyBiologicalProcess | circadian behavior | 9.97e-04 | 71 | 128 | 4 | GO:0048512 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 1.02e-03 | 123 | 128 | 5 | GO:0120034 | |
| GeneOntologyBiologicalProcess | social behavior | 1.16e-03 | 74 | 128 | 4 | GO:0035176 | |
| GeneOntologyBiologicalProcess | rhythmic behavior | 1.16e-03 | 74 | 128 | 4 | GO:0007622 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 1.16e-03 | 74 | 128 | 4 | GO:0051932 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 1.18e-03 | 335 | 128 | 8 | GO:0043087 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 9.34e-08 | 19 | 130 | 5 | GO:1902711 | |
| GeneOntologyCellularComponent | intercellular bridge | 1.28e-07 | 94 | 130 | 8 | GO:0045171 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.62e-07 | 21 | 130 | 5 | GO:1902710 | |
| GeneOntologyCellularComponent | postsynapse | GABRB1 GABRB2 GABRB3 GABRR1 ABI1 FMR1 FRMPD4 ATR FXR2 ACHE CAMK2B CAMK2D LRFN3 GABRQ CLSTN2 NLGN1 ITGB4 MET FXR1 CNTNAP2 | 4.80e-06 | 1018 | 130 | 20 | GO:0098794 |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRB1 FMR1 FRMPD4 FXR2 ACHE CAMK2B CAMK2D LRFN3 CLSTN2 NLGN1 OPA1 TGFB3 MET GDPD5 TUBB3 TUBB4A FXR1 SACS CNTNAP2 CACNA1G KLHL14 IL6ST | 6.69e-06 | 1228 | 130 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRB1 GABRB2 GABRB3 GABRR1 FMR1 ACHE LRFN3 GABRQ CLSTN2 NLGN1 ITGB4 MET | 8.76e-06 | 405 | 130 | 12 | GO:0045211 |
| GeneOntologyCellularComponent | dendrite | GABRB1 FMR1 FRMPD4 FXR2 ACHE CAMK2B LRFN3 CLSTN2 NLGN1 OPA1 MET TUBB3 FXR1 SACS CNTNAP2 CACNA1G IL6ST | 2.39e-05 | 858 | 130 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GABRB1 FMR1 FRMPD4 FXR2 ACHE CAMK2B LRFN3 CLSTN2 NLGN1 OPA1 MET TUBB3 FXR1 SACS CNTNAP2 CACNA1G IL6ST | 2.46e-05 | 860 | 130 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | chloride channel complex | 2.78e-05 | 57 | 130 | 5 | GO:0034707 | |
| GeneOntologyCellularComponent | mitotic spindle | 3.79e-05 | 201 | 130 | 8 | GO:0072686 | |
| GeneOntologyCellularComponent | receptor complex | GABRB1 GABRB2 GABRB3 TRAV9-1 GABRR1 GFRAL GABRQ NLGN1 ITGB4 MET IL6ST TRAV23DV6 PLXNB1 | 6.93e-05 | 581 | 130 | 13 | GO:0043235 |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 GABRB2 GABRB3 GABRR1 FMR1 ACHE LRFN3 GABRQ CLSTN2 NLGN1 ITGB4 MET CNTNAP2 | 7.17e-05 | 583 | 130 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 7.57e-05 | 164 | 130 | 7 | GO:0098982 | |
| GeneOntologyCellularComponent | tubulin complex | 1.15e-04 | 3 | 130 | 2 | GO:0045298 | |
| GeneOntologyCellularComponent | microtubule | CENPE TUBB TUBB2B OPA1 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B EML5 CDK5RAP2 DNAH8 | 1.26e-04 | 533 | 130 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | glutamatergic synapse | GABRB2 GABRR1 ABI1 FMR1 FRMPD4 FXR2 CAMK2B LRFN3 CLSTN2 NLGN1 ITGB4 FXR1 SV2B CNTNAP2 CTBP2 | 1.72e-04 | 817 | 130 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | cell body | FMR1 ACHE CAMK2B CAMK2D TUBB TGFB3 MET GDPD5 CCT6A TUBB3 TUBB4A CNTNAP2 CACNA1G KLHL14 GSTO1 IL6ST | 2.15e-04 | 929 | 130 | 16 | GO:0044297 |
| GeneOntologyCellularComponent | filopodium tip | 2.48e-04 | 20 | 130 | 3 | GO:0032433 | |
| GeneOntologyCellularComponent | blood microparticle | 2.85e-04 | 144 | 130 | 6 | GO:0072562 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 3.79e-04 | 5 | 130 | 2 | GO:0005954 | |
| GeneOntologyCellularComponent | axon | GABRB3 ABI1 FMR1 ACHE CAMK2D LRFN3 OPA1 GDPD5 TUBB3 TUBB4A FXR1 SACS AVIL CNTNAP2 GSTO1 | 4.34e-04 | 891 | 130 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | U2AF complex | 7.90e-04 | 7 | 130 | 2 | GO:0089701 | |
| GeneOntologyCellularComponent | basement membrane | 9.98e-04 | 122 | 130 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular fiber | CENPE TUBB TUBB2B OPA1 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B AKAP4 FXR1 EML5 AVIL CDK5RAP2 ASB2 DNAH8 MYBPC1 | 1.03e-03 | 1179 | 130 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | IgM immunoglobulin complex, circulating | 1.05e-03 | 8 | 130 | 2 | GO:0071754 | |
| GeneOntologyCellularComponent | pentameric IgM immunoglobulin complex | 1.05e-03 | 8 | 130 | 2 | GO:0071756 | |
| GeneOntologyCellularComponent | supramolecular polymer | CENPE TUBB TUBB2B OPA1 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B AKAP4 FXR1 EML5 AVIL CDK5RAP2 ASB2 DNAH8 MYBPC1 | 1.11e-03 | 1187 | 130 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | postsynaptic specialization | GABRB1 GABRB2 GABRB3 ABI1 FMR1 FRMPD4 CAMK2B LRFN3 CLSTN2 NLGN1 | 1.21e-03 | 503 | 130 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | presynapse | GABRB1 GABRB2 GABRB3 GABRR1 FMR1 ATR FXR2 ACHE LRFN3 NLGN1 FXR1 SV2B CNTNAP2 CTBP2 | 1.25e-03 | 886 | 130 | 14 | GO:0098793 |
| GeneOntologyCellularComponent | monomeric IgA immunoglobulin complex | 1.34e-03 | 9 | 130 | 2 | GO:0071748 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.43e-03 | 78 | 130 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.63e-03 | 201 | 130 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | polymeric IgA immunoglobulin complex | 1.67e-03 | 10 | 130 | 2 | GO:0071749 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex, circulating | 1.67e-03 | 10 | 130 | 2 | GO:0071746 | |
| GeneOntologyCellularComponent | secretory IgA immunoglobulin complex | 1.67e-03 | 10 | 130 | 2 | GO:0071751 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.76e-03 | 277 | 130 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.90e-03 | 141 | 130 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | neuronal cell body | FMR1 ACHE CAMK2B CAMK2D TGFB3 MET GDPD5 TUBB3 TUBB4A CNTNAP2 CACNA1G KLHL14 IL6ST | 2.13e-03 | 835 | 130 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | spindle | 2.76e-03 | 471 | 130 | 9 | GO:0005819 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex | 3.82e-03 | 15 | 130 | 2 | GO:0071745 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex | 3.82e-03 | 15 | 130 | 2 | GO:0071753 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 3.83e-03 | 166 | 130 | 5 | GO:0019814 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CENPE TUBB TUBB2B OPA1 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B EML5 AVIL CDK5RAP2 DNAH8 | 4.00e-03 | 899 | 130 | 13 | GO:0099513 |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 4.91e-03 | 17 | 130 | 2 | GO:0042571 | |
| HumanPheno | Dysgenesis of the basal ganglia | 6.81e-06 | 5 | 46 | 3 | HP:0025102 | |
| HumanPheno | Partial agenesis of the corpus callosum | 1.10e-05 | 58 | 46 | 6 | HP:0001338 | |
| Domain | Beta-tubulin_BS | 1.64e-11 | 10 | 125 | 6 | IPR013838 | |
| Domain | Beta_tubulin | 1.64e-11 | 10 | 125 | 6 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 3.58e-11 | 11 | 125 | 6 | PS00228 | |
| Domain | - | 2.86e-09 | 20 | 125 | 6 | 3.30.1330.20 | |
| Domain | - | 3.98e-09 | 21 | 125 | 6 | 1.10.287.600 | |
| Domain | Tubulin_C | 5.44e-09 | 22 | 125 | 6 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 5.44e-09 | 22 | 125 | 6 | IPR018316 | |
| Domain | - | 5.44e-09 | 22 | 125 | 6 | 3.40.50.1440 | |
| Domain | Tubulin_C | 5.44e-09 | 22 | 125 | 6 | SM00865 | |
| Domain | Tub_FtsZ_C | 7.32e-09 | 23 | 125 | 6 | IPR008280 | |
| Domain | Tubulin_C | 7.32e-09 | 23 | 125 | 6 | IPR023123 | |
| Domain | TUBULIN | 7.32e-09 | 23 | 125 | 6 | PS00227 | |
| Domain | Tubulin | 7.32e-09 | 23 | 125 | 6 | IPR000217 | |
| Domain | Tubulin | 7.32e-09 | 23 | 125 | 6 | SM00864 | |
| Domain | Tubulin_CS | 7.32e-09 | 23 | 125 | 6 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 9.71e-09 | 24 | 125 | 6 | IPR003008 | |
| Domain | Tubulin | 9.71e-09 | 24 | 125 | 6 | PF00091 | |
| Domain | Agenet | 2.93e-07 | 3 | 125 | 3 | PF05641 | |
| Domain | AGENET_LIKE | 2.93e-07 | 3 | 125 | 3 | PS51641 | |
| Domain | FXMRP1_C_core | 2.93e-07 | 3 | 125 | 3 | IPR022034 | |
| Domain | Agenet-like_dom | 2.93e-07 | 3 | 125 | 3 | IPR008395 | |
| Domain | GABAAb_rcpt | 2.93e-07 | 3 | 125 | 3 | IPR002289 | |
| Domain | FXMRP1_C_core | 2.93e-07 | 3 | 125 | 3 | PF12235 | |
| Domain | GABAA/Glycine_rcpt | 3.79e-07 | 23 | 125 | 5 | IPR006028 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.22e-05 | 45 | 125 | 5 | IPR018000 | |
| Domain | Neur_chan_memb | 1.36e-05 | 46 | 125 | 5 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 1.52e-05 | 47 | 125 | 5 | IPR006029 | |
| Domain | - | 1.52e-05 | 47 | 125 | 5 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 1.52e-05 | 47 | 125 | 5 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.52e-05 | 47 | 125 | 5 | PS00236 | |
| Domain | Neur_channel | 1.52e-05 | 47 | 125 | 5 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.52e-05 | 47 | 125 | 5 | IPR006202 | |
| Domain | FXR_C1 | 4.44e-05 | 2 | 125 | 2 | IPR032172 | |
| Domain | FXR_C1 | 4.44e-05 | 2 | 125 | 2 | PF16096 | |
| Domain | CaMKII_AD | 2.64e-04 | 4 | 125 | 2 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 2.64e-04 | 4 | 125 | 2 | IPR013543 | |
| Domain | Apc4_WD40_dom | 3.07e-04 | 20 | 125 | 3 | IPR024977 | |
| Domain | ANAPC4_WD40 | 3.07e-04 | 20 | 125 | 3 | PF12894 | |
| Domain | U2AF_small | 4.39e-04 | 5 | 125 | 2 | IPR009145 | |
| Domain | Gal_Oxidase_b-propeller | 1.50e-03 | 34 | 125 | 3 | IPR015916 | |
| Domain | EGF_1 | 1.66e-03 | 255 | 125 | 7 | PS00022 | |
| Domain | EGF-like_CS | 1.89e-03 | 261 | 125 | 7 | IPR013032 | |
| Domain | KH_1 | 2.08e-03 | 38 | 125 | 3 | PF00013 | |
| Domain | - | 2.24e-03 | 39 | 125 | 3 | 3.30.1370.10 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 2.67e-11 | 20 | 91 | 7 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 3.92e-10 | 28 | 91 | 7 | M47898 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | GABRB1 GABRB2 GABRB3 GABRR1 CAMK2B CAMK2D GABRQ TUBB2B TUBB6 TUBB3 TUBB4A TUBB4B GNAL | 6.30e-10 | 205 | 91 | 13 | M752 |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 7.16e-10 | 17 | 91 | 6 | M47768 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | GABRB1 GABRB2 GABRB3 GABRR1 ACHE CAMK2B CAMK2D LRFN3 GJC1 GABRQ TUBB2B NLGN1 TUBB6 TUBB3 TUBB4A TUBB4B GNAL | 9.10e-10 | 411 | 91 | 17 | M735 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.07e-09 | 18 | 91 | 6 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.55e-09 | 19 | 91 | 6 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.55e-09 | 19 | 91 | 6 | M47813 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | GABRB1 GABRB2 GABRB3 GABRR1 ACHE CAMK2B CAMK2D GABRQ TUBB2B TUBB6 TUBB3 TUBB4A TUBB4B GNAL | 1.83e-09 | 270 | 91 | 14 | M15514 |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 2.21e-09 | 20 | 91 | 6 | M47911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.07e-09 | 21 | 91 | 6 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 4.20e-09 | 22 | 91 | 6 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 5.66e-09 | 23 | 91 | 6 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 5.66e-09 | 23 | 91 | 6 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 7.51e-09 | 24 | 91 | 6 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.51e-09 | 24 | 91 | 6 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 9.83e-09 | 25 | 91 | 6 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 9.83e-09 | 25 | 91 | 6 | M47710 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 9.86e-09 | 43 | 91 | 7 | M47669 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.17e-08 | 44 | 91 | 7 | M27934 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.27e-08 | 26 | 91 | 6 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.27e-08 | 26 | 91 | 6 | M47672 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.37e-08 | 45 | 91 | 7 | M47670 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 4.85e-08 | 32 | 91 | 6 | MM14730 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 5.84e-08 | 17 | 91 | 5 | MM14731 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 5.90e-08 | 33 | 91 | 6 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 5.90e-08 | 33 | 91 | 6 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 8.55e-08 | 35 | 91 | 6 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.43e-07 | 38 | 91 | 6 | M14981 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.88e-07 | 21 | 91 | 5 | M27067 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 3.08e-07 | 23 | 91 | 5 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 3.08e-07 | 43 | 91 | 6 | M47773 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 3.55e-07 | 44 | 91 | 6 | MM14606 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 7.24e-07 | 27 | 91 | 5 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 7.24e-07 | 27 | 91 | 5 | MM15674 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 8.73e-07 | 51 | 91 | 6 | M26972 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.05e-06 | 29 | 91 | 5 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.05e-06 | 29 | 91 | 5 | M27948 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.38e-06 | 55 | 91 | 6 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.53e-06 | 56 | 91 | 6 | M2333 | |
| Pathway | REACTOME_KINESINS | 1.71e-06 | 57 | 91 | 6 | MM15714 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.76e-06 | 32 | 91 | 5 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.76e-06 | 32 | 91 | 5 | M27491 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.79e-06 | 90 | 91 | 7 | MM14979 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.32e-06 | 60 | 91 | 6 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.32e-06 | 60 | 91 | 6 | M976 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.40e-06 | 94 | 91 | 7 | M2843 | |
| Pathway | REACTOME_KINESINS | 2.56e-06 | 61 | 91 | 6 | M977 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.58e-06 | 95 | 91 | 7 | M6729 | |
| Pathway | REACTOME_AGGREPHAGY | 3.23e-06 | 36 | 91 | 5 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.72e-06 | 37 | 91 | 5 | MM15102 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.06e-06 | 144 | 91 | 8 | MM14501 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 6.26e-06 | 71 | 91 | 6 | M39690 | |
| Pathway | REACTOME_AGGREPHAGY | 8.93e-06 | 44 | 91 | 5 | M29830 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 9.74e-06 | 116 | 91 | 7 | MM15715 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | GABRB1 GABRB2 GABRB3 GABRR1 CAMK2B CAMK2D LRFN3 GJC1 GABRQ NLGN1 GNAL | 1.01e-05 | 335 | 91 | 11 | MM14503 |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.12e-05 | 46 | 91 | 5 | M27828 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.38e-05 | 48 | 91 | 5 | MM15353 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.53e-05 | 49 | 91 | 5 | M891 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.05e-05 | 52 | 91 | 5 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.05e-05 | 52 | 91 | 5 | MM15211 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.25e-05 | 53 | 91 | 5 | M27651 | |
| Pathway | KEGG_GAP_JUNCTION | 2.47e-05 | 90 | 91 | 6 | M4013 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.47e-05 | 54 | 91 | 5 | M27482 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 3.02e-05 | 138 | 91 | 7 | MM15635 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.22e-05 | 57 | 91 | 5 | M27251 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.00e-05 | 98 | 91 | 6 | MM15352 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 4.00e-05 | 98 | 91 | 6 | M776 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 4.47e-05 | 31 | 91 | 4 | M39369 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.49e-05 | 100 | 91 | 6 | M27650 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 4.75e-05 | 202 | 91 | 8 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 5.10e-05 | 204 | 91 | 8 | M4217 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 5.76e-05 | 33 | 91 | 4 | M39875 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 6.47e-05 | 211 | 91 | 8 | MM14502 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 6.57e-05 | 66 | 91 | 5 | MM17074 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 7.59e-05 | 68 | 91 | 5 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 7.59e-05 | 68 | 91 | 5 | MM14968 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 9.98e-05 | 72 | 91 | 5 | M26954 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 1.01e-04 | 38 | 91 | 4 | M39854 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.03e-04 | 116 | 91 | 6 | MM14855 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.07e-04 | 73 | 91 | 5 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.07e-04 | 73 | 91 | 5 | MM15672 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.13e-04 | 170 | 91 | 7 | M941 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.29e-04 | 76 | 91 | 5 | M48037 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.29e-04 | 76 | 91 | 5 | M27215 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.55e-04 | 79 | 91 | 5 | M27743 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.62e-04 | 126 | 91 | 6 | M705 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.69e-04 | 127 | 91 | 6 | M27181 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.84e-04 | 129 | 91 | 6 | MM14894 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 1.85e-04 | 184 | 91 | 7 | MM15145 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 1.92e-04 | 130 | 91 | 6 | MM14627 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.01e-04 | 131 | 91 | 6 | MM15497 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.27e-04 | 134 | 91 | 6 | M27751 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.33e-04 | 191 | 91 | 7 | M29614 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.48e-04 | 193 | 91 | 7 | MM14890 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | KLHL2 DET1 CENPE UBR4 TUBB2B TUBB6 MALT1 TUBB3 TUBB4A TUBB4B DAPP1 ASB2 IGKV4-1 IGKV3-15 ANAPC4 | 2.50e-04 | 828 | 91 | 15 | M1058 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.80e-04 | 261 | 91 | 8 | MM15676 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.86e-04 | 90 | 91 | 5 | M29841 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.87e-04 | 140 | 91 | 6 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.99e-04 | 141 | 91 | 6 | MM15266 | |
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 7.42e-14 | 8 | 132 | 6 | 23246003 | |
| Pubmed | 1.38e-10 | 21 | 132 | 6 | 30110642 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 1.89e-10 | 22 | 132 | 6 | 16526095 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 1.89e-10 | 22 | 132 | 6 | 23826228 | |
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 1.89e-10 | 22 | 132 | 6 | 30446499 | |
| Pubmed | Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells. | 9.88e-10 | 5 | 132 | 4 | 21296049 | |
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 1.47e-09 | 54 | 132 | 7 | 21525035 | |
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 3782288 | ||
| Pubmed | 2.96e-09 | 6 | 132 | 4 | 24275654 | ||
| Pubmed | 6.01e-09 | 18 | 132 | 5 | 19078961 | ||
| Pubmed | Targeting Peripheral Somatosensory Neurons to Improve Tactile-Related Phenotypes in ASD Models. | 6.88e-09 | 7 | 132 | 4 | 31398341 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | TOR1AIP2 FMR1 POLR1A FXR2 TUBB MCM3 TUBB2B EFTUD2 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B FXR1 | 3.60e-08 | 565 | 132 | 14 | 33567341 |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | POLR1A ERH ATR CAMK2D TUBB MCM3 EFTUD2 CCT6A TUBB3 TUBB4A TUBB4B | 3.94e-08 | 317 | 132 | 11 | 17620599 |
| Pubmed | Spatial control of nucleoporin condensation by fragile X-related proteins. | 5.34e-08 | 3 | 132 | 3 | 32706158 | |
| Pubmed | The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. | 5.34e-08 | 3 | 132 | 3 | 7489725 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 8668200 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 27770568 | ||
| Pubmed | Tubulin beta 3 and 4 are involved in the generation of early fibrotic stages. | 5.34e-08 | 3 | 132 | 3 | 28648944 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 19487368 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 20442204 | ||
| Pubmed | LLPS of FXR proteins drives replication organelle clustering for β-coronaviral proliferation. | 5.34e-08 | 3 | 132 | 3 | 38587486 | |
| Pubmed | GABAA receptor beta 1, beta 2, and beta 3 subunits: comparisons in DBA/2J and C57BL/6J mice. | 5.34e-08 | 3 | 132 | 3 | 7893750 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 1282920 | ||
| Pubmed | Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. | 5.34e-08 | 3 | 132 | 3 | 9259278 | |
| Pubmed | Fragile X-related proteins regulate mammalian circadian behavioral rhythms. | 5.34e-08 | 3 | 132 | 3 | 18589395 | |
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 12417522 | ||
| Pubmed | 5.34e-08 | 3 | 132 | 3 | 10888599 | ||
| Pubmed | Evidence that fragile X mental retardation protein is a negative regulator of translation. | 5.34e-08 | 3 | 132 | 3 | 11157796 | |
| Pubmed | Expression and distribution of GABAA receptor subtypes in human alcoholic cerebral cortex. | 5.34e-08 | 3 | 132 | 3 | 11085308 | |
| Pubmed | GABAA receptor beta subunit mRNA expression in the human alcoholic brain. | 5.34e-08 | 3 | 132 | 3 | 15337300 | |
| Pubmed | Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer. | 5.34e-08 | 3 | 132 | 3 | 32878499 | |
| Pubmed | Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes. | 5.34e-08 | 3 | 132 | 3 | 26612855 | |
| Pubmed | 7.26e-08 | 198 | 132 | 9 | 24337577 | ||
| Pubmed | FMR1 FN1 ERH FXR2 TUBB MCM3 TUBB2B TUBB3 TUBB4A TUBB4B FXR1 IGKV4-1 | 8.00e-08 | 421 | 132 | 12 | 34650049 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 9.58e-08 | 12 | 132 | 4 | 15331610 | |
| Pubmed | 9.64e-08 | 30 | 132 | 5 | 25864199 | ||
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 1.38e-07 | 13 | 132 | 4 | 10908577 | |
| Pubmed | ABI1 FMR1 ERH CENPE DOCK11 FXR2 CAMK2B CAMK2D UBR4 MCM3 TUBB2B OPA1 EFTUD2 TUBB6 FXR1 CDK5RAP2 CTBP2 | 1.57e-07 | 963 | 132 | 17 | 28671696 | |
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 12486001 | ||
| Pubmed | Translational animal models of autism and neurodevelopmental disorders. | 1.93e-07 | 14 | 132 | 4 | 23226954 | |
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 10556305 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 10567518 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 16571602 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 11120798 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 18664458 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 19545277 | ||
| Pubmed | 2.13e-07 | 4 | 132 | 3 | 28130256 | ||
| Pubmed | 3.47e-07 | 173 | 132 | 8 | 23979707 | ||
| Pubmed | 4.32e-07 | 40 | 132 | 5 | 30865227 | ||
| Pubmed | 4.54e-07 | 17 | 132 | 4 | 17360745 | ||
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 5.31e-07 | 125 | 132 | 7 | 36030824 | |
| Pubmed | 5.31e-07 | 5 | 132 | 3 | 15198677 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | UBR4 TUBB MCM3 SMARCAD1 PDCD4 EFTUD2 TUBB6 CCT6A TUBB4A TUBB4B | 6.12e-07 | 332 | 132 | 10 | 32786267 |
| Pubmed | 6.27e-07 | 187 | 132 | 8 | 26460568 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FMR1 POLR1A FRMPD4 ERH FXR2 TUBB MCM3 TUBB2B PDCD4 EFTUD2 CCT6A TUBB4A TUBB4B FXR1 IGKV3-15 ADGRA3 | 6.84e-07 | 949 | 132 | 16 | 36574265 |
| Pubmed | 7.35e-07 | 19 | 132 | 4 | 15698476 | ||
| Pubmed | 7.35e-07 | 19 | 132 | 4 | 15691386 | ||
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 11438699 | ||
| Pubmed | The GABAA Receptor β Subunit Is Required for Inhibitory Transmission. | 1.06e-06 | 6 | 132 | 3 | 29706582 | |
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 27293187 | ||
| Pubmed | 1.06e-06 | 6 | 132 | 3 | 18613978 | ||
| Pubmed | Evolution of GABA(A) receptor diversity in the human genome. | 1.06e-06 | 6 | 132 | 3 | 10023064 | |
| Pubmed | 1.13e-06 | 21 | 132 | 4 | 25708312 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 1.85e-06 | 7 | 132 | 3 | 20843900 | |
| Pubmed | theta, a novel gamma-aminobutyric acid type A receptor subunit. | 1.85e-06 | 7 | 132 | 3 | 10449790 | |
| Pubmed | 1.85e-06 | 7 | 132 | 3 | 27010057 | ||
| Pubmed | GABRB3 ABI1 FMR1 FN1 CAMK2B CAMK2D TUBB TUBB2B OPA1 CCT6A TUBB3 TUBB4A TUBB4B FXR1 SACS SV2B HRG LSAMP IGKV4-1 | 2.07e-06 | 1431 | 132 | 19 | 37142655 | |
| Pubmed | 2.95e-06 | 8 | 132 | 3 | 11528422 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | POLR1A UBR4 TUBB MCM3 TUBB2B SMARCAD1 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B FXR1 DNAH8 | 3.05e-06 | 704 | 132 | 13 | 29955894 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 3.46e-06 | 235 | 132 | 8 | 28378594 | |
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | ABI1 TUBB MCM3 TUBB2B TUBB6 CCT6A TUBB4A TUBB4B FXR1 SH3PXD2A | 4.79e-06 | 418 | 132 | 10 | 32552912 |
| Pubmed | 4.98e-06 | 329 | 132 | 9 | 35562734 | ||
| Pubmed | Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. | 5.22e-06 | 176 | 132 | 7 | 18614564 | |
| Pubmed | TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. | 5.84e-06 | 67 | 132 | 5 | 34644545 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | TOR1AIP2 POLR1A CAMK2B CAMK2D UBR4 TUBB MCM3 TUBB2B OPA1 EFTUD2 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B FXR1 CTBP2 | 5.89e-06 | 1257 | 132 | 17 | 37317656 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | TOR1AIP2 CAMK2D UBR4 TUBB TUBB2B EFTUD2 CCT6A TUBB3 NTN4 TUBB4A TUBB4B ANAPC4 | 6.28e-06 | 639 | 132 | 12 | 23443559 |
| Pubmed | 6.74e-06 | 183 | 132 | 7 | 23956138 | ||
| Pubmed | 7.65e-06 | 441 | 132 | 10 | 31239290 | ||
| Pubmed | 8.33e-06 | 72 | 132 | 5 | 36123327 | ||
| Pubmed | FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124. | 8.62e-06 | 11 | 132 | 3 | 21957233 | |
| Pubmed | Synapse formation by hippocampal neurons from agrin-deficient mice. | 8.62e-06 | 11 | 132 | 3 | 9882498 | |
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 22022532 | ||
| Pubmed | 8.62e-06 | 11 | 132 | 3 | 29142209 | ||
| Pubmed | 1.06e-05 | 36 | 132 | 4 | 31669268 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | CCPG1 FN1 CENPE DOCK11 ZRSR2 EFTUD2 ZRSR2P1 CDK5RAP2 CACNA1G | 1.09e-05 | 363 | 132 | 9 | 14691545 |
| Pubmed | 1.17e-05 | 463 | 132 | 10 | 34901782 | ||
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | ERH TUBB MCM3 TUBB2B SMARCAD1 TUBB6 TUBB3 TUBB4B PWWP3A IGKV4-1 | 1.28e-05 | 468 | 132 | 10 | 36042349 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CCPG1 ERH UBR4 TUBB MCM3 CLSTN2 EFTUD2 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B CACNA1G | 1.31e-05 | 807 | 132 | 13 | 30575818 |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12581522 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 19932134 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26950270 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23486367 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 33691379 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30345304 | ||
| Pubmed | Differential distribution of beta-tubulin isotypes in cerebellum. | 1.43e-05 | 2 | 132 | 2 | 2461292 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17225872 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 32898154 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22438565 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8634689 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12196556 | ||
| Interaction | CAPS interactions | 7.73e-09 | 25 | 124 | 6 | int:CAPS | |
| Interaction | OSTM1 interactions | 3.27e-08 | 80 | 124 | 8 | int:OSTM1 | |
| Interaction | TPSB2 interactions | 6.53e-08 | 18 | 124 | 5 | int:TPSB2 | |
| Interaction | TTC5 interactions | 1.46e-07 | 65 | 124 | 7 | int:TTC5 | |
| Interaction | TCP11L1 interactions | 3.95e-07 | 75 | 124 | 7 | int:TCP11L1 | |
| Interaction | GABRA1 interactions | 4.22e-07 | 152 | 124 | 9 | int:GABRA1 | |
| Interaction | ZC2HC1B interactions | 7.14e-07 | 28 | 124 | 5 | int:ZC2HC1B | |
| Interaction | EML1 interactions | 1.68e-06 | 33 | 124 | 5 | int:EML1 | |
| Interaction | PEX14 interactions | CCL4L1 TUBB TUBB2B TUBB6 CCT6A TUBB3 TUBB4A TUBB4B VPS13D CCL4 | 2.12e-06 | 237 | 124 | 10 | int:PEX14 |
| Interaction | FAM86B2 interactions | 2.35e-06 | 16 | 124 | 4 | int:FAM86B2 | |
| Interaction | TRIM31 interactions | FMR1 FN1 ERH FXR2 TUBB MCM3 TUBB2B CCT6A TUBB3 TUBB4A TUBB4B FXR1 IGKV4-1 | 4.60e-06 | 454 | 124 | 13 | int:TRIM31 |
| Interaction | DNAJA4 interactions | 9.25e-06 | 79 | 124 | 6 | int:DNAJA4 | |
| Interaction | TMPRSS5 interactions | 1.13e-05 | 48 | 124 | 5 | int:TMPRSS5 | |
| Interaction | SOCS1 interactions | 1.40e-05 | 177 | 124 | 8 | int:SOCS1 | |
| Interaction | CACNB1 interactions | 1.56e-05 | 25 | 124 | 4 | int:CACNB1 | |
| Interaction | ASB17 interactions | 1.56e-05 | 25 | 124 | 4 | int:ASB17 | |
| Interaction | RSPH1 interactions | 1.67e-05 | 131 | 124 | 7 | int:RSPH1 | |
| Interaction | FGR interactions | 2.37e-05 | 93 | 124 | 6 | int:FGR | |
| Interaction | TUBB8B interactions | 3.62e-05 | 11 | 124 | 3 | int:TUBB8B | |
| Interaction | ZBTB3 interactions | 4.64e-05 | 64 | 124 | 5 | int:ZBTB3 | |
| Interaction | TUBA1B interactions | ABI1 FN1 TUBB TUBB2B EFTUD2 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B CNTNAP2 PAN2 | 5.90e-05 | 498 | 124 | 12 | int:TUBA1B |
| Interaction | WEE2-AS1 interactions | 6.78e-05 | 163 | 124 | 7 | int:WEE2-AS1 | |
| Interaction | CAMKMT interactions | 6.91e-05 | 36 | 124 | 4 | int:CAMKMT | |
| Interaction | LGALS3BP interactions | 7.03e-05 | 286 | 124 | 9 | int:LGALS3BP | |
| Interaction | SPRTN interactions | TOR1AIP2 FXR2 TUBB MCM3 TUBB2B EFTUD2 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B NAA25 CTBP2 | 7.92e-05 | 596 | 124 | 13 | int:SPRTN |
| Interaction | WDR77 interactions | 8.03e-05 | 361 | 124 | 10 | int:WDR77 | |
| Interaction | SHC1 interactions | 8.22e-05 | 362 | 124 | 10 | int:SHC1 | |
| Interaction | NT5C2 interactions | 8.61e-05 | 117 | 124 | 6 | int:NT5C2 | |
| Interaction | DNAL4 interactions | 9.51e-05 | 39 | 124 | 4 | int:DNAL4 | |
| Interaction | CST11 interactions | 9.95e-05 | 75 | 124 | 5 | int:CST11 | |
| Interaction | DLG4 interactions | GABRB1 GABRB2 ABI1 FMR1 FRMPD4 CAMK2B CAMK2D TUBB2B NLGN1 TUBB6 CNTNAP2 | 1.05e-04 | 449 | 124 | 11 | int:DLG4 |
| Interaction | SLFN11 interactions | CCPG1 POLR1A TUBB PDCD4 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B CTBP2 | 1.12e-04 | 376 | 124 | 10 | int:SLFN11 |
| Interaction | C1QA interactions | 1.13e-04 | 77 | 124 | 5 | int:C1QA | |
| Interaction | USP11 interactions | FMR1 POLR1A CENPE TUBB MCM3 TUBB2B TUBB6 TUBB3 TUBB4A TUBB4B FXR1 ATG4C | 1.25e-04 | 539 | 124 | 12 | int:USP11 |
| Interaction | ARL2 interactions | 1.67e-04 | 132 | 124 | 6 | int:ARL2 | |
| Interaction | GAN interactions | 1.74e-04 | 253 | 124 | 8 | int:GAN | |
| Interaction | GBA1 interactions | 1.74e-04 | 133 | 124 | 6 | int:GBA1 | |
| Interaction | TUBB4B interactions | ABI1 FN1 UBR4 TUBB TUBB2B EFTUD2 TUBB6 CCT6A TUBB3 TUBB4A TUBB4B PAN2 | 1.78e-04 | 560 | 124 | 12 | int:TUBB4B |
| Interaction | CECR2 interactions | 1.82e-04 | 46 | 124 | 4 | int:CECR2 | |
| Interaction | CLEC14A interactions | 1.90e-04 | 86 | 124 | 5 | int:CLEC14A | |
| Interaction | IL12RB1 interactions | 2.01e-04 | 87 | 124 | 5 | int:IL12RB1 | |
| Interaction | EML4 interactions | 2.05e-04 | 137 | 124 | 6 | int:EML4 | |
| Interaction | BUB1 interactions | 2.05e-04 | 137 | 124 | 6 | int:BUB1 | |
| Interaction | PHC1P1 interactions | 2.24e-04 | 4 | 124 | 2 | int:PHC1P1 | |
| Interaction | RAI2 interactions | 2.40e-04 | 20 | 124 | 3 | int:RAI2 | |
| Interaction | LINC01554 interactions | 2.49e-04 | 142 | 124 | 6 | int:LINC01554 | |
| Interaction | PCBP1 interactions | FMR1 FN1 ERH FXR2 TUBB SMARCAD1 EFTUD2 TUBB6 MET CCT6A TUBB4B PAN2 CTBP2 | 2.54e-04 | 671 | 124 | 13 | int:PCBP1 |
| Interaction | MCM5 interactions | FN1 CAMK2B CAMK2D TUBB MCM3 TUBB2B EFTUD2 TUBB3 TUBB4A TUBB4B | 2.74e-04 | 420 | 124 | 10 | int:MCM5 |
| Interaction | TUBB2B interactions | 2.80e-04 | 205 | 124 | 7 | int:TUBB2B | |
| Interaction | PPEF1 interactions | 2.94e-04 | 52 | 124 | 4 | int:PPEF1 | |
| Interaction | TSHR interactions | 3.18e-04 | 96 | 124 | 5 | int:TSHR | |
| Interaction | CDC42SE2 interactions | 3.21e-04 | 22 | 124 | 3 | int:CDC42SE2 | |
| Interaction | TCF7 interactions | 3.68e-04 | 23 | 124 | 3 | int:TCF7 | |
| Interaction | ARHGEF7 interactions | 3.71e-04 | 153 | 124 | 6 | int:ARHGEF7 | |
| Interaction | NME3 interactions | 3.84e-04 | 100 | 124 | 5 | int:NME3 | |
| Interaction | NIN interactions | 3.84e-04 | 359 | 124 | 9 | int:NIN | |
| Interaction | BTF3 interactions | ABI1 FMR1 ERH FXR2 TUBB MCM3 TUBB2B OPA1 PDCD4 EFTUD2 TUBB6 TUBB4B FXR1 IGKV4-1 | 4.06e-04 | 799 | 124 | 14 | int:BTF3 |
| Interaction | RPGR interactions | 4.19e-04 | 57 | 124 | 4 | int:RPGR | |
| Interaction | MGARP interactions | 4.53e-04 | 222 | 124 | 7 | int:MGARP | |
| Cytoband | 9q22.33 | 1.19e-04 | 33 | 132 | 3 | 9q22.33 | |
| Cytoband | 2p12 | 3.76e-04 | 117 | 132 | 4 | 2p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 3.94e-04 | 213 | 132 | 5 | chr2p11 | |
| GeneFamily | Tubulins | 3.56e-09 | 26 | 94 | 6 | 778 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.74e-08 | 19 | 94 | 5 | 563 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 9.20e-04 | 83 | 94 | 4 | 351 | |
| GeneFamily | Kelch like|BTB domain containing | 1.35e-03 | 42 | 94 | 3 | 617 | |
| GeneFamily | Fibronectin type III domain containing | 1.49e-03 | 160 | 94 | 5 | 555 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | GABRB1 GABRB2 GABRB3 SGTB FRMPD4 CAMK2B ATP8A2 TUBB2B NLGN1 TUBB3 EML5 SV2B CNTNAP2 LSAMP CACNA1G GNAL | 3.48e-07 | 703 | 128 | 16 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GABRB2 GABRB3 CCPG1 FRMPD4 SLC16A9 CAMK2B ARFGEF1 TUBB2B NLGN1 TUBB3 SV2B SH3PXD2A CNTNAP2 LSAMP CACNA1G GNAL KLHL14 ZMAT1 PDZRN4 | 1.83e-06 | 1106 | 128 | 19 | M39071 |
| Coexpression | GSE19512_NAUTRAL_VS_INDUCED_TREG_DN | 6.53e-06 | 200 | 128 | 8 | M8359 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | GABRB1 GABRB3 CAMK2B TUBB2B CLSTN2 TUBB3 SV2B SH3PXD2A LSAMP GNAL KLHL14 PDZRN4 | 7.36e-06 | 506 | 128 | 12 | M39067 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | GABRB1 GABRB3 SGTB FRMPD4 CAMK2B ATP8A2 TUBB2B GDPD5 TUBB3 LSAMP GNAL PDZRN4 | 3.04e-05 | 584 | 128 | 12 | M39068 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | GABRB1 GABRB3 FRMPD4 ATP8A2 TUBB2B TUBB3 SV2B SH3PXD2A CNTNAP2 GNAL PDZRN4 | 4.50e-05 | 513 | 128 | 11 | M39069 |
| Coexpression | CHANG_POU5F1_TARGETS_UP | 4.96e-05 | 15 | 128 | 3 | M9138 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN | 5.70e-05 | 199 | 128 | 7 | M5092 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | GABRB1 ABI1 FMR1 ATR DOCK11 ZRSR2 NBEAL1 HEMGN MCM3 YOD1 EML5 MEIOC SACS KCTD14 RBM5 DNAH8 | 9.64e-06 | 776 | 122 | 16 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_500 | 2.17e-05 | 98 | 122 | 6 | gudmap_developingKidney_e13.5_podocyte cells_500_k3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.73e-08 | 186 | 132 | 8 | 24b23880d4ff8fb4a23e2012d5890b9e2fcf7283 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius-36|World / Primary Cells by Cluster | 1.25e-07 | 195 | 132 | 8 | bc76a0586cc78f013cb96a2444e63e3c5daa3bc7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius|World / Primary Cells by Cluster | 1.25e-07 | 195 | 132 | 8 | 424d8e2bc7f7e68f74219de06dbbb671c8b4c24c | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 1.47e-07 | 199 | 132 | 8 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.28e-07 | 142 | 132 | 7 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-07 | 174 | 132 | 7 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.01e-06 | 177 | 132 | 7 | 370aee11a6dc2c6f4366a13c3171f37bc5b32d65 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-06 | 184 | 132 | 7 | 4cb5f299dd7413e0be1ad7af817ee614b23a18ae | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-06 | 184 | 132 | 7 | 39bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.36e-06 | 185 | 132 | 7 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.86e-06 | 194 | 132 | 7 | 30f683725cb13ae32ef6846618801ec78e12397d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-06 | 197 | 132 | 7 | a1ae1aa797762a3768e14434c7e5cd19c595ecb3 | |
| ToppCell | BAL-Mild-cDC_10|Mild / Compartment, Disease Groups and Clusters | 2.06e-06 | 197 | 132 | 7 | c0550d41dd5619b369b590f3d6a61154dd7b2cab | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-06 | 197 | 132 | 7 | 5593721407f61fc5bc3f2f8bf8fa2604c4e29565 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-06 | 200 | 132 | 7 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-06 | 200 | 132 | 7 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.28e-06 | 200 | 132 | 7 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-06 | 200 | 132 | 7 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.87e-06 | 140 | 132 | 6 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, Lineage and Cell Type | 8.04e-06 | 159 | 132 | 6 | f6ad73b6a3681471efbd4fafd9eb631764c53500 | |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | 1.10e-05 | 168 | 132 | 6 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-05 | 171 | 132 | 6 | fa5cc720bd0045d0307439be547b41d56def5b43 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 1.43e-05 | 176 | 132 | 6 | 5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.43e-05 | 176 | 132 | 6 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.43e-05 | 176 | 132 | 6 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 183 | 132 | 6 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 183 | 132 | 6 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.84e-05 | 184 | 132 | 6 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|normal_Lung / Location, Cell class and cell subclass | 1.96e-05 | 186 | 132 | 6 | 0987c9a39503eb6c75a2bf4db98b2b2fd46956fb | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.96e-05 | 186 | 132 | 6 | 00ad1239b952119b3fd2e6af8f034cba3488f9c1 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 187 | 132 | 6 | 99724aa3dbdcb073ea3bfe80cc825ecae5495db8 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 189 | 132 | 6 | a959c9d6a0866582688a4204d625c1e5a123e93d | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.21e-05 | 190 | 132 | 6 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.21e-05 | 190 | 132 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 191 | 132 | 6 | 08be56a4055a73c920d345fd3b2052a5ccb675d8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 191 | 132 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.34e-05 | 192 | 132 | 6 | 2c69f3f388b69fb1c1968c923cdbab90658883dd | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.34e-05 | 192 | 132 | 6 | d5a7b546ebfb2e757dd9c64cb1b651f6ed0e0fc7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.41e-05 | 193 | 132 | 6 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.41e-05 | 193 | 132 | 6 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.41e-05 | 193 | 132 | 6 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.41e-05 | 193 | 132 | 6 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.41e-05 | 193 | 132 | 6 | d9be4d1de863fffc2240d6fd1a2f8dfb2d2bc916 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.48e-05 | 194 | 132 | 6 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.55e-05 | 195 | 132 | 6 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | tumor_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.55e-05 | 195 | 132 | 6 | 72a7c4beb880390b29f3c5d6dd9dbb082af50fe2 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 2.55e-05 | 195 | 132 | 6 | 339e81a3a5b1f71c0d15ef1ef0f6999378704923 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 195 | 132 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.63e-05 | 196 | 132 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.63e-05 | 196 | 132 | 6 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-05 | 196 | 132 | 6 | 36b4f08fc038dfde6343ff0869e1a027d882adb5 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 197 | 132 | 6 | 3a0e97bfebe82f9687d518baaad7f20d0ffea8a1 | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|COVID-19 / Condition, Lineage and Cell class | 2.70e-05 | 197 | 132 | 6 | b6d6cdae33753c1e38394f1f879e00b87f9c0496 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 198 | 132 | 6 | 62059185afdf66126a6fbc899ce611c47e7a0feb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-05 | 198 | 132 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.78e-05 | 198 | 132 | 6 | 8d1c74a728040386316fbdcabcdea5fb2b5a76a1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 198 | 132 | 6 | 50504a3871f76d6a5b439a56450d7770f4501eb0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-05 | 198 | 132 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-05 | 198 | 132 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-05 | 198 | 132 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.78e-05 | 198 | 132 | 6 | 5080767ff55326b7d94fca27d398237c4a15c1ed | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 198 | 132 | 6 | 800ade4261695f2efd869d2b1243571de963c431 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-05 | 198 | 132 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|Myeloid / Condition, Lineage and Cell class | 2.78e-05 | 198 | 132 | 6 | 90f3b227cbc61c268d6d94bc9945a08d83d2d3d5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 2.86e-05 | 199 | 132 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-05 | 199 | 132 | 6 | b4824d3683a4e3025b8e74a0f1755b331b2a0ba7 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-Neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-05 | 199 | 132 | 6 | 0c5a5fbb174a013be10961f0db65c65c797ab4af | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 2.86e-05 | 199 | 132 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-05 | 199 | 132 | 6 | b2508bf591720830e8e3494b1337aab14539956d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-05 | 199 | 132 | 6 | a255484ba77bd2741a541da278efc8cf4abbe570 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-05 | 199 | 132 | 6 | be425e9cb90a73289026b1b7cb581e1c02a8985e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 200 | 132 | 6 | 31dd81df9aa754a1e69b905bf9b8ce73ff8175aa | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.94e-05 | 200 | 132 | 6 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 200 | 132 | 6 | 54174a485a82480726fa06efa6e050ddea77cb3c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 200 | 132 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.79e-05 | 133 | 132 | 5 | fc319644868078ea0f88a71d55f5e858c6848b50 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.15e-05 | 135 | 132 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 6.99e-05 | 144 | 132 | 5 | 76c0e551864c4faab7528c4ecf1a40d7ea60569f | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-05 | 145 | 132 | 5 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 159 | 132 | 5 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.12e-04 | 159 | 132 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 160 | 132 | 5 | 8dae9b0cf90a09acb196223f45a14680102630b2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 160 | 132 | 5 | af84da18c85037f49f55e8958f00f12140226982 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 160 | 132 | 5 | f7ca98beaa24f9674d503588eb15d341c4135d77 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 160 | 132 | 5 | a76ad44b5f25f59d6b9333fb45f8bb96196a3090 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.18e-04 | 161 | 132 | 5 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Cajal-Retzius|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.22e-04 | 162 | 132 | 5 | 1f589a763f3fd4e1e612809ef3903879d47dc1d8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 163 | 132 | 5 | c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 163 | 132 | 5 | 99cf60dc87f7ce288553091bffcd85109a02bd8f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 163 | 132 | 5 | 510c0af66e82c5a8cf8edd0547dae4018a87dbbf | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 164 | 132 | 5 | a67dd181eba275c191f4d0cab13df30eaa3ad913 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-04 | 164 | 132 | 5 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-04 | 164 | 132 | 5 | 67c636a2cc32e56c6186dc7e779cc19af04639d2 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-04 | 164 | 132 | 5 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 165 | 132 | 5 | 8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.33e-04 | 165 | 132 | 5 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 166 | 132 | 5 | 5c132f505dc5f699c87913f140344fc9f8e7e0f5 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-04 | 167 | 132 | 5 | 43a9375fdbafd7450c553e4620e21537e08639dd | |
| Drug | 2-phenyl-4-quinolone | 1.21e-11 | 34 | 127 | 8 | CID000161091 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 3.34e-10 | 31 | 127 | 7 | CID000032851 | |
| Drug | L-quisqualic acid | GABRB1 GABRB2 GABRB3 GABRR1 ACHE TUBB GABRQ TUBB2B TUBB6 TUBB3 TUBB4A TUBB4B | 4.03e-10 | 180 | 127 | 12 | CID000001209 |
| Drug | E2-3,4-Q | 4.26e-10 | 32 | 127 | 7 | CID000067402 | |
| Drug | 2,5-hexanedione | 8.51e-10 | 56 | 127 | 8 | CID000008035 | |
| Drug | AC1O5Y0F | 1.27e-09 | 37 | 127 | 7 | CID006442852 | |
| Drug | DTAF | 1.27e-09 | 37 | 127 | 7 | CID000123934 | |
| Drug | bromocolchicine | 1.35e-09 | 21 | 127 | 6 | CID000161518 | |
| Drug | colchifoline | 1.35e-09 | 21 | 127 | 6 | CID000100132 | |
| Drug | Ustiloxin A | 1.35e-09 | 21 | 127 | 6 | CID000164454 | |
| Drug | SRI-3072 | 1.35e-09 | 21 | 127 | 6 | CID000493469 | |
| Drug | 3,4,5-trimethoxyacetophenone | 1.85e-09 | 22 | 127 | 6 | CID000014345 | |
| Drug | AC1L1GIQ | 1.85e-09 | 22 | 127 | 6 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 1.85e-09 | 22 | 127 | 6 | CID000098538 | |
| Drug | SureCN13401588 | 1.85e-09 | 22 | 127 | 6 | CID009897422 | |
| Drug | N-methyldemecolcine | 1.85e-09 | 22 | 127 | 6 | CID000023759 | |
| Drug | NSC-339672 | 1.85e-09 | 22 | 127 | 6 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 2.50e-09 | 23 | 127 | 6 | CID000006858 | |
| Drug | AC1L2P05 | 2.50e-09 | 23 | 127 | 6 | CID000125688 | |
| Drug | 2,3,4-tabp | 2.50e-09 | 23 | 127 | 6 | CID000125548 | |
| Drug | NSC-373301 | 2.50e-09 | 23 | 127 | 6 | CID000341375 | |
| Drug | NSC355636 | 2.50e-09 | 23 | 127 | 6 | CID000100176 | |
| Drug | IKP104 | 2.50e-09 | 23 | 127 | 6 | CID000130739 | |
| Drug | fluorescein-colchicine | 2.50e-09 | 23 | 127 | 6 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 2.50e-09 | 23 | 127 | 6 | CID000084076 | |
| Drug | 2,3,4-TCB | 2.50e-09 | 23 | 127 | 6 | CID000129239 | |
| Drug | N-acetylcolchinol | 2.50e-09 | 23 | 127 | 6 | CID000097865 | |
| Drug | indanone | 2.73e-09 | 41 | 127 | 7 | CID000006735 | |
| Drug | parbendazole | 3.31e-09 | 24 | 127 | 6 | CID000026596 | |
| Drug | tropolone methyl ether | 3.31e-09 | 24 | 127 | 6 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 3.31e-09 | 24 | 127 | 6 | CID000330401 | |
| Drug | NABV | 3.31e-09 | 24 | 127 | 6 | CID000175959 | |
| Drug | AC1L4TG7 | 3.31e-09 | 24 | 127 | 6 | CID000163705 | |
| Drug | moscatilin | 3.31e-09 | 24 | 127 | 6 | CID000176096 | |
| Drug | NSC-36768 | 3.31e-09 | 24 | 127 | 6 | CID000165441 | |
| Drug | deacetamidocolchicine | 3.31e-09 | 24 | 127 | 6 | CID000014995 | |
| Drug | colchicide | 3.31e-09 | 24 | 127 | 6 | CID000120712 | |
| Drug | Stylophorin | 3.88e-09 | 43 | 127 | 7 | CID000010147 | |
| Drug | mpMap | 4.34e-09 | 25 | 127 | 6 | CID000100806 | |
| Drug | AC1Q6P06 | 4.34e-09 | 25 | 127 | 6 | CID000160263 | |
| Drug | allocolchicine | 4.34e-09 | 25 | 127 | 6 | CID000196989 | |
| Drug | 1069C85 | 4.34e-09 | 25 | 127 | 6 | CID006918099 | |
| Drug | 55623-37-5 | 4.34e-09 | 25 | 127 | 6 | CID006438440 | |
| Drug | MDL 27048 | 4.34e-09 | 25 | 127 | 6 | CID006439188 | |
| Drug | NBD-colcemid | 4.34e-09 | 25 | 127 | 6 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 4.34e-09 | 25 | 127 | 6 | CID000043264 | |
| Drug | CA1P | 4.34e-09 | 25 | 127 | 6 | CID006918545 | |
| Drug | peloruside A | 4.34e-09 | 25 | 127 | 6 | CID006918506 | |
| Drug | NSC142227 | 4.34e-09 | 25 | 127 | 6 | CID000073427 | |
| Drug | NSC527981 | 5.62e-09 | 26 | 127 | 6 | CID000352796 | |
| Drug | NSC332029 | 5.62e-09 | 26 | 127 | 6 | CID000100073 | |
| Drug | indibulin | 5.62e-09 | 26 | 127 | 6 | CID000002929 | |
| Drug | pironetin | 5.62e-09 | 26 | 127 | 6 | CID006438891 | |
| Drug | isaxonine | 5.62e-09 | 26 | 127 | 6 | CID000071169 | |
| Drug | AC1L1J4H | 7.19e-09 | 27 | 127 | 6 | CID000004862 | |
| Drug | dinitroanilines | 7.19e-09 | 27 | 127 | 6 | CID000136400 | |
| Drug | NSC292222 | 7.19e-09 | 27 | 127 | 6 | CID000099957 | |
| Drug | NSC D-669356 | 7.19e-09 | 27 | 127 | 6 | CID000178028 | |
| Drug | NSC 370147 | 9.11e-09 | 28 | 127 | 6 | CID000182762 | |
| Drug | NSC72302 | 9.11e-09 | 28 | 127 | 6 | CID000118078 | |
| Drug | bp U | 1.14e-08 | 29 | 127 | 6 | CID000368697 | |
| Drug | oxibendazole | 1.14e-08 | 29 | 127 | 6 | CID000004622 | |
| Drug | Aids106696 | 1.14e-08 | 29 | 127 | 6 | CID006475933 | |
| Drug | ddGDP | 1.14e-08 | 29 | 127 | 6 | CID000134739 | |
| Drug | TK-B | 1.34e-08 | 51 | 127 | 7 | CID000009074 | |
| Drug | AC1NBBHE | 1.42e-08 | 30 | 127 | 6 | CID004490620 | |
| Drug | eleutherobin | 1.42e-08 | 30 | 127 | 6 | CID006918335 | |
| Drug | azatoxin | 1.42e-08 | 30 | 127 | 6 | CID000125383 | |
| Drug | NSC617668 | 1.42e-08 | 30 | 127 | 6 | CID000357989 | |
| Drug | citostal | 1.42e-08 | 30 | 127 | 6 | CID000018991 | |
| Drug | thiocolchicine | 1.42e-08 | 30 | 127 | 6 | CID000017648 | |
| Drug | procaine | GABRB2 ACHE TUBB GABRQ TUBB2B TUBB6 TUBB3 TUBB4A TUBB4B CACNA1G | 1.49e-08 | 153 | 127 | 10 | CID000004914 |
| Drug | B-Ms | 1.55e-08 | 114 | 127 | 9 | CID000445091 | |
| Drug | NSC609395 | 1.76e-08 | 31 | 127 | 6 | CID005488798 | |
| Drug | amiprophosmethyl | 1.76e-08 | 31 | 127 | 6 | CID000100524 | |
| Drug | AC7700 | 1.76e-08 | 31 | 127 | 6 | CID006918404 | |
| Drug | tropone | 1.76e-08 | 31 | 127 | 6 | CID000010881 | |
| Drug | AC1L3V8I | 1.76e-08 | 31 | 127 | 6 | CID000122777 | |
| Drug | NSC332598 | 1.76e-08 | 31 | 127 | 6 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 1.76e-08 | 31 | 127 | 6 | CID000023678 | |
| Drug | AC1L1G95 | 2.15e-08 | 32 | 127 | 6 | CID000003583 | |
| Drug | NSC153858 | 2.15e-08 | 32 | 127 | 6 | CID000547450 | |
| Drug | 2-demethylcolchicine | 2.15e-08 | 32 | 127 | 6 | CID000023757 | |
| Drug | mebendazole | 2.62e-08 | 33 | 127 | 6 | CID000004030 | |
| Drug | CA4P | 2.62e-08 | 33 | 127 | 6 | CID000370232 | |
| Drug | taltobulin | 2.62e-08 | 33 | 127 | 6 | CID006918637 | |
| Drug | dihydroxyaflavinine | 2.93e-08 | 17 | 127 | 5 | CID000156857 | |
| Drug | triethyllead | 3.16e-08 | 34 | 127 | 6 | CID006328106 | |
| Drug | NSC376450 | 3.16e-08 | 34 | 127 | 6 | CID000005605 | |
| Drug | discodermolide | 3.80e-08 | 35 | 127 | 6 | CID000643668 | |
| Drug | plumbagin | 4.83e-08 | 61 | 127 | 7 | CID000010205 | |
| Drug | secobarbital | 5.40e-08 | 37 | 127 | 6 | CID000005193 | |
| Drug | albendazole | 5.40e-08 | 37 | 127 | 6 | CID000002082 | |
| Drug | baccatin III | 5.40e-08 | 37 | 127 | 6 | CID000065366 | |
| Drug | Adinazolam | 6.35e-08 | 8 | 127 | 4 | DB00546 | |
| Drug | Fludiazepam | 6.35e-08 | 8 | 127 | 4 | DB01567 | |
| Drug | Clotiazepam | 6.35e-08 | 8 | 127 | 4 | DB01559 | |
| Drug | Cinolazepam | 6.35e-08 | 8 | 127 | 4 | DB01594 | |
| Drug | Prazepam | 6.35e-08 | 8 | 127 | 4 | DB01588 | |
| Drug | Estazolam | 6.35e-08 | 8 | 127 | 4 | DB01215 | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 1.35e-14 | 12 | 122 | 7 | DOID:0050997 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 9.14e-13 | 10 | 122 | 6 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 9.14e-13 | 10 | 122 | 6 | DOID:0112227 (implicated_via_orthology) | |
| Disease | facial paralysis (implicated_via_orthology) | 9.14e-13 | 10 | 122 | 6 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 9.14e-13 | 10 | 122 | 6 | DOID:0090132 (implicated_via_orthology) | |
| Disease | Schizophrenia | GABRB1 GABRB2 GABRB3 GABRR1 FMR1 ACHE CAMK2B GABRQ NLGN1 OPA1 CFAP65 MET EML5 SH3PXD2A NR2E1 CNTNAP2 LSAMP GNAL | 2.52e-08 | 883 | 122 | 18 | C0036341 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 5.34e-08 | 49 | 122 | 6 | DOID:0060037 (implicated_via_orthology) | |
| Disease | fragile X syndrome (implicated_via_orthology) | 6.90e-08 | 3 | 122 | 3 | DOID:14261 (implicated_via_orthology) | |
| Disease | malignant pleural mesothelioma (implicated_via_orthology) | 6.90e-08 | 3 | 122 | 3 | DOID:7474 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.42e-06 | 152 | 122 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 3.80e-06 | 8 | 122 | 3 | DOID:14452 (implicated_via_orthology) | |
| Disease | autistic disorder (is_implicated_in) | 2.76e-05 | 42 | 122 | 4 | DOID:12849 (is_implicated_in) | |
| Disease | Congenital Fibrosis of the Extraocular Muscles | 5.07e-05 | 3 | 122 | 2 | C1302995 | |
| Disease | Colorectal Carcinoma | FN1 ZNF560 ARFGEF1 CLSTN2 SACS RASL11A PAN2 DNAH8 IL6ST ANAPC4 PDZRN4 | 1.64e-04 | 702 | 122 | 11 | C0009402 |
| Disease | Dysequilibrium syndrome | 1.68e-04 | 5 | 122 | 2 | C0394006 | |
| Disease | Bipolar Disorder | 1.70e-04 | 477 | 122 | 9 | C0005586 | |
| Disease | epididymis-specific alpha-mannosidase measurement | 3.51e-04 | 7 | 122 | 2 | EFO_0801577 | |
| Disease | microcephaly (is_implicated_in) | 4.67e-04 | 8 | 122 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | osteoarthritis, spine, body mass index | 4.67e-04 | 8 | 122 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | mean fractional anisotropy measurement | 6.62e-04 | 95 | 122 | 4 | EFO_0008399 | |
| Disease | COVID-19, mortality | 7.21e-04 | 170 | 122 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | Autistic Disorder | 7.77e-04 | 261 | 122 | 6 | C0004352 | |
| Disease | status epilepticus (biomarker_via_orthology) | 8.03e-04 | 100 | 122 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, obsolete_red blood cell distribution width, basophil count, platelet count, eosinophil count | 9.10e-04 | 11 | 122 | 2 | EFO_0004305, EFO_0004308, EFO_0004309, EFO_0004526, EFO_0004528, EFO_0004584, EFO_0004833, EFO_0004842, EFO_0005090, EFO_0005091, EFO_0005192 | |
| Disease | white matter microstructure measurement | 1.22e-03 | 390 | 122 | 7 | EFO_0005674 | |
| Disease | sensory peripheral neuropathy, response to platinum based chemotherapy | 1.28e-03 | 13 | 122 | 2 | EFO_0004647, MONDO_0002321 | |
| Disease | Autosomal recessive primary microcephaly | 1.72e-03 | 15 | 122 | 2 | cv:C3711387 | |
| Disease | white matter integrity | 2.12e-03 | 130 | 122 | 4 | EFO_0004641 | |
| Disease | Benign neoplasm of stomach | 2.21e-03 | 17 | 122 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.21e-03 | 17 | 122 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.21e-03 | 17 | 122 | 2 | C0154060 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 2.21e-03 | 17 | 122 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | ovarian neoplasm | 2.36e-03 | 134 | 122 | 4 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 2.56e-03 | 137 | 122 | 4 | C1140680 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.63e-03 | 447 | 122 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 2.63e-03 | 447 | 122 | 7 | C3714756 | |
| Disease | Chronic myeloproliferative disorder | 2.77e-03 | 19 | 122 | 2 | C1292778 | |
| Disease | ceramide measurement | 2.99e-03 | 235 | 122 | 5 | EFO_0010222 | |
| Disease | stroke | 3.06e-03 | 144 | 122 | 4 | EFO_0000712 | |
| Disease | Headache, HbA1c measurement | 3.38e-03 | 21 | 122 | 2 | EFO_0004541, HP_0002315 | |
| Disease | Stomach Carcinoma | 3.38e-03 | 21 | 122 | 2 | C0699791 | |
| Disease | Seckel syndrome | 3.71e-03 | 22 | 122 | 2 | C0265202 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDAYILTCNVSLEYE | 226 | P40227 | |
| VDATTFQSVCYQYVD | 91 | P22303 | |
| EQSCAAIYTTQLDDY | 71 | O75366 | |
| YSCLDAQFYDDETVT | 636 | Q9UJX5 | |
| VSDTQNYECLPEATY | 881 | Q9BXX2 | |
| VYTLQDLLYQSDCVS | 226 | P56545 | |
| YNILTQEDAQSVYDA | 156 | P07357 | |
| SSENCYSVYADQVNI | 151 | Q5JQC9 | |
| QVEGNEECTYDYVAV | 191 | Q5VXM1 | |
| QCTIGQEEYSLYSSL | 11 | Q96Q27 | |
| DENITTIQCYSLSNY | 726 | Q8IWK6 | |
| CADAQSVVDIYVNYD | 556 | Q9Y6D6 | |
| SVVDIYVNYDCDLNA | 561 | Q9Y6D6 | |
| QSTVYSYIQDHVCVS | 566 | Q9Y3Q7 | |
| ESYQNLTRVADYCEN | 21 | Q8IZP0 | |
| VDQTYSEELCYTLIN | 76 | Q8N6F7 | |
| SSDQTSLEIYEYQGC | 76 | Q7L5Y6 | |
| QYSQICNYEIVTTDV | 191 | Q9H4D0 | |
| TLCVAYADLSENEYE | 626 | Q9NTI2 | |
| ITIYVAQDCTVYNSD | 256 | Q96DT6 | |
| YSDQTSYLSICLEEN | 626 | Q96SN8 | |
| NVEEIGTCSYINYVI | 106 | Q6ZS30 | |
| YYSSSTIECNQGEQE | 646 | Q6ZMN7 | |
| ECVYTISLASAQEDY | 36 | Q9NRC9 | |
| SQSEYLIYQESQCRL | 511 | Q9Y6F1 | |
| ADNSCLFTSVYYVVE | 156 | Q5VVQ6 | |
| VNVFSYRNTCVEVSY | 701 | Q6IE37 | |
| YTATVTITCQYFDDR | 121 | Q7RTY1 | |
| DDYISTQEQVVDYLT | 1026 | Q504Q3 | |
| VVDRNTISYYACAAQ | 86 | Q8NH50 | |
| YQTELVENECYQVFL | 26 | Q9H496 | |
| SLVCQDTSQYEYTVL | 201 | Q8NG84 | |
| VYYLVLDVQESDCSV | 66 | P04196 | |
| YAACDATYNEIVTLE | 106 | P51116 | |
| QLIYESAITCEYLDE | 81 | P78417 | |
| VCLSYQYSGLEDTVE | 686 | Q9UDY8 | |
| YAACDATYNEIVTFE | 96 | P51114 | |
| ACNLVVESYGYTVED | 196 | Q9UN88 | |
| SSLEAEDAATYYCQQ | 96 | A0A0C4DH26 | |
| YKVLQSYSNIEEDCT | 736 | Q6ZU64 | |
| NFVVDYYETSSLCSQ | 46 | P13236 | |
| NTYIDSYKGTVDCVQ | 276 | Q53EL6 | |
| TEVAYIEYDVNSDCA | 351 | O43157 | |
| DLSCLVYRADTQTYQ | 66 | P84090 | |
| SYFLSDYNIVCSSEI | 2991 | Q96JB1 | |
| DEQNCTLEIESYGYT | 171 | P18505 | |
| DVLSVCSDNSYDTYA | 566 | Q8WTR4 | |
| EQNCTLEIESYGYTT | 171 | P47870 | |
| DEQNCTLEIESYGYT | 171 | P28472 | |
| SILQSEDFAVYYCQQ | 96 | A0A087WSY6 | |
| TYDLCVLAVYEDSAT | 491 | Q9BTN0 | |
| VVSSYVQDQSEDCLY | 141 | Q8N2Q7 | |
| VQDQSEDCLYLNIYV | 146 | Q8N2Q7 | |
| QSLYTDTICEINYSA | 606 | P16144 | |
| ESVQSVDYYCDTIIL | 221 | P52756 | |
| ICQESNIYQENFSEY | 136 | Q9BXL5 | |
| NDVTAIIYVAACSSY | 226 | P38405 | |
| VLTQESATYIAEEYS | 581 | P25205 | |
| VLDVLSDYDASYNTQ | 271 | O60313 | |
| QFETTCNYVEATLEE | 86 | Q96EW2 | |
| SAAYAIQELLSIYDC | 1416 | Q13535 | |
| YLSQCQQEQESFIDY | 261 | Q9ULG6 | |
| YAACDATYNEIVTIE | 96 | Q06787 | |
| TCSLEIESYAYTEDD | 211 | P24046 | |
| SCTVDYSTVYFVNIE | 181 | P40189 | |
| GYLSSVECYNLETNE | 436 | Q9P2G3 | |
| SNDCLNVATEETVFY | 186 | Q9NXS3 | |
| NFVVDYYETSSLCSQ | 46 | Q8NHW4 | |
| VQDSNLEYSLSDEYC | 1096 | Q5JSL3 | |
| DQESTCYNTVISPIY | 1816 | O43497 | |
| EYTSQTNNCTYLREQ | 16 | Q6UXV0 | |
| YSQLRDQCIVDDITY | 511 | P02751 | |
| YNITIYAVEENQEST | 876 | P02751 | |
| ESIYYDEQSKFVCNT | 41 | P36383 | |
| EYLYVQSCNDVVQER | 306 | Q14CM0 | |
| LSYSFEYVILNEDCQ | 91 | P51841 | |
| TECSAVQFDYSQERV | 211 | Q9UN19 | |
| YYVATDINECTDFVD | 126 | P09871 | |
| AYAANVYTSVVEELA | 51 | Q9Y2E5 | |
| NDTIIDIFNDYATYC | 211 | Q86Z14 | |
| SSLQSEDFAVYYCQQ | 96 | P01624 | |
| ISSLQAEDVAVYYCQ | 101 | P06312 | |
| QISAITDSAEYCEQY | 671 | Q9UHC6 | |
| AYTAYCQDLFSETEL | 496 | O00219 | |
| TYLAVGCNDSSVDIY | 421 | Q05BV3 | |
| DSYSSYCNAVAEAEI | 431 | Q08357 | |
| STCYNTADIYSLVDE | 1661 | Q9NZJ4 | |
| NVYVADLTEEVVYTS | 161 | Q02224 | |
| EYYSEADASHCIQQI | 106 | Q13557 | |
| YLYEVATESVCESAA | 176 | Q9Y466 | |
| QTNSLRAEDTAVYYC | 101 | A0A0C4DH35 | |
| LDAQSVYVATDSESY | 301 | Q9H488 | |
| VVDTYYDDQLISCGS | 121 | P08581 | |
| LSSSQYVTCVETYLE | 606 | Q2TAK8 | |
| ISTSENYEDVCDVFQ | 176 | Q6T310 | |
| CSFYEVSVSENYNDV | 176 | Q9BPW5 | |
| EYYSEADASHCIQQI | 106 | Q13554 | |
| FYDCYTSQSEDNVDL | 61 | A2RUB1 | |
| AEAYVLACTDQQYLV | 606 | O95602 | |
| QDEGTYICQITTSLY | 276 | Q9BX59 | |
| DYNVIVTTYNCAISS | 596 | Q9H4L7 | |
| NCTIESTIFYNTDLY | 491 | Q7L1I2 | |
| VDVYDEGSYTCSVQT | 101 | Q13449 | |
| NATELYCFYSENTDL | 56 | Q9HB63 | |
| CEDTNVRVYYVATSS | 541 | Q8IZU2 | |
| CLVETEEQDAYYSEV | 171 | Q9BQ13 | |
| ASLYAISNVCEEYIV | 206 | Q8IXU6 | |
| EDDTVTEYIYHCNVQ | 241 | Q8WTS1 | |
| QLYDVCSDSANVYAT | 101 | Q7RTX1 | |
| TDETYCIDNEALYDI | 196 | Q9BUF5 | |
| TDETYCIDNEALYDI | 196 | P04350 | |
| VEYYTIAEFQSCISD | 451 | Q5TCZ1 | |
| SVSDESNDLLYQYCD | 326 | Q8N3Z0 | |
| TDETYCIDNEALYDI | 196 | Q9BVA1 | |
| TDETYCIDNEALYDI | 196 | P68371 | |
| TDETYCIDNEALYDI | 196 | P07437 | |
| TDETYCIDNEALYDI | 196 | Q13509 | |
| RYALSYNSDVVSECS | 406 | Q5T7W7 | |
| DSLIVNCSYETTQYP | 36 | A0A075B6T8 | |
| YAAAVDCYTQAIELD | 101 | Q96EQ0 | |
| YVQYQSEEECQAALS | 276 | Q15695 | |
| VDVDQTAVYTQYFDI | 61 | Q9NX01 | |
| ISIINCAYENTAFDY | 46 | A0A075B6W5 | |
| YDQDLCYTDILFTEQ | 161 | Q15029 | |
| RTYEYDDIAQVCVVS | 396 | A5PLN9 | |
| DFYENYQASTETLQC | 3646 | Q5T4S7 | |
| YVQYQSEEECQAALS | 271 | Q15696 | |
| CTQENTESEYYAKEI | 91 | P10600 | |
| ADYYCNTLTASQVDQ | 746 | Q9BYX2 | |
| TNCYQYSVTFEDTAV | 6 | Q96MR9 | |
| SNYSVCDQRTNYVID | 406 | Q9NX78 | |
| TQDSYQNECADYINV | 216 | Q5H9K5 | |
| YQSTYEQNTEVAVEI | 1156 | Q5THJ4 | |
| IDYVYTAEIQVTEEN | 111 | O95198 | |
| QCQISSFYLVNDIYE | 771 | Q14CX7 | |
| INNCQMTDDSEYYVT | 311 | Q00872 |